Previous 10 | Next 10 |
2024-04-23 10:00:21 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Tech advances are catalyzing the Health Care sector with improved ...
2024-04-22 17:25:00 ET More on T2 Biosystems T2 Biosystems shareholders vote to convert $15M CRG debt into equity T2 Biosystems receives extension to comply with Nasdaq listing requirement Financial information for T2 Biosystems Read the full article on See...
2024-04-14 08:00:00 ET More on related stocks: Prologis: Waiting For Godot And $80 Bank of America: No Good Incentive To Turn Bullish Ahead Of Q1 Earnings United Airlines: Buy The Dip Now And Fly First Class Later Morgan Stanley wealth unit said to be probed ...
2024-04-11 16:24:35 ET More on T2 Biosystems T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript T2 Biosystems receives extension to comply with Nasdaq listing requirement T2 Biosystems says it achieved full year 2023 total revenue of $7.2M Financial ...
LEXINGTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced results from the special meeting of stockholders on April 11, 2024. T2 Biosystems Stockholders voted...
2024-03-28 09:36:30 ET More on T2 Biosystems T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript T2 Biosystems receives extension to comply with Nasdaq listing requirement T2 Biosystems says it achieved full year 2023 total revenue of $7.2M Seeking Al...
LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that its multi-year capital equipment supplier agreement with Vizient, Inc., the largest member-driv...
LEXINGTON, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans for the T2Lyme Panel commercial launch and provided recent busin...
LEXINGTON, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that Company management will host a conference call to discuss the T2L...
LEXINGTON, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the publication of a new study highlighting the clinical benefits...
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it received written notice from the Nasdaq Stock Market LLC (ȁ...
2024-05-17 18:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LEXINGTON, Mass., May 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has closed its previously announced private placement for the purchase and sale of an aggregat...